Track TetraLogic Pharmaceuticals's total liabilities ($74M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
TetraLogic Pharmaceuticals (TLOG) currently reports a total liabilities of $74M as of September 2016. That compares with $86M in the prior-year period — down 14.3% year over year. Use the charts on this page to explore TetraLogic Pharmaceuticals's total liabilities history and peer comparisons.
TetraLogic Pharmaceuticals's total liabilities decreased from $86M to $74M — a 14.3% year-over-year decrease (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
TetraLogic Pharmaceuticals reported $74M in total liabilities as of September 2016. That compares with $86M in the prior-year period — down 14.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $74M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TetraLogic Pharmaceuticals, and consider following TLOG for alerts when major investors trade the stock.
TetraLogic Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $74M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLOG with unrelated industries.